Similar articles

• [High risk group and screening methods of hepatocellular carcinoma].

  Matsushita E, Kaneko S, Kobayashi K. Matsushita E, et al. Nihon Rinsho. 2001 Oct;59 Suppl 6:229-35. Nihon Rinsho. 2001. PMID: 11761945 Review. Japanese. No abstract available.
• [Informed consent for high risk group of hepatocellular carcinoma].

  Yamada G. Yamada G. Nihon Rinsho. 2001 Oct;59 Suppl 6:812-6. Nihon Rinsho. 2001. PMID: 11762062 Review. Japanese. No abstract available.
• Hepatocellular carcinoma: status in the era of liver transplantation.

  Singhal A, Jabbour N. Singhal A, et al. J Okla State Med Assoc. 2009 Dec;102(12):355-61. J Okla State Med Assoc. 2009. PMID: 20131731 Review. No abstract available.
• [Epidemiology of malignant liver tumors].

  Rodella S, Picoco C. Rodella S, et al. Ann Ist Super Sanita. 1996;32(4):595-610. Ann Ist Super Sanita. 1996. PMID: 9382428 Review. Italian.
• Detection of hepatocellular cancer during screening of 1125 patients with chronic hepatitis virus infection.

  Izzo F, Cremona F, Ruffolo F, Palaia R, Parisi V, Curley S. Izzo F, et al. J Chemother. 1997 Apr;9(2):151-2. doi: 10.1179/joc.1997.9.2.151. J Chemother. 1997. PMID: 9176768 Clinical Trial. No abstract available.